Calculation of agonist efficacy, apparent affinity, and receptor population changes after administration of insurmountable antagonists: Comparison of different analytical approaches

Gerald Zernig1, Tom Issaevitch2, James H. Woods1,3
1Department of Pharmacology, University of Michigan, Ann Arbor, MI, USA
2Wolfram Research Inc., Champaign, IL, USA
3Department of Psychology, University of Michigan, Ann Arbor, MI, USA

Tài liệu tham khảo

Besse, 1976, Dissociation constants and relative efficacies of agonists acting on alpha adrenergic receptors in rabbit aorta, J Pharmacol Exp Ther, 197, 66 Black, 1985, An operational model of pharmacological antagonism: The effect of E[A] curve shape on agonist dissociation constant estimation, Br J Pharmacol, 84, 561, 10.1111/j.1476-5381.1985.tb12941.x Black, 1983, Operational models of pharmacological agonism, 220, 141 Black, 1995, Inverse agonists exposed, Nature, 374, 214, 10.1038/374214a0 Chidiae, 1995, Receptor state and ligand efficacy, Trends Pharmacol Sci, 16, 83, 10.1016/S0165-6147(00)88986-5 Colquhoun, 1989, Validity of the operational model, Trends Pharmacol Sci, 10, 17, 10.1016/0165-6147(89)90100-4 Comer, 1993, Discriminative stimulus effects of BW373U86: A nonpeptide ligand with selectivity for delta opioid receptors, J Pharmacol Exp Ther, 267, 866 Cox, 1991, Opioid tolerance and dependence, 199 France, 1984, Discriminative stimulus effects of reversible and irreversible opiate agonists: Morphine, oxymorphazone and buprenorphine, J Pharmacol Exp Ther, 230, 652 France, 1991, MK-801 and related compounds in monkeys: discriminative stimulus effects and effects on a conditional discrimination published erratum appears, J Pharmacol Exp Ther, 259, 1404 France, 1991, MK-801 and related compounds in monkeys: discriminative stimulus effects and effects on a conditional discrimination published erratum appears, J Pharmacol Exp Ther, 257, 727 Furchgott, 1966, The use of β-haloalkylamines in the differentiation of receptors and in the determination of dissociation constants of receptor-agonist complexes, Adv Drug Res, 3, 21 Furchgott, 1967, Comparison of dissociation constants and or relative efficacies of selected agonists acting on parasympathetic receptors, Ann NY Acad Sci, 144, 882, 10.1111/j.1749-6632.1967.tb53817.x Harden, 1983, Agonist-induced desensitization of the beta-adrenergic receptor-linked adenylate cyclase, Pharmacol Rev, 35, 5 Hopkins, 1987 Jenkinson, 1989, Finding affinity constants for agonists by the irreversible agonist method, Trends Pharmacol Sci, 10, 16, 10.1016/0165-6147(89)90099-0 Kenakin, 1994, On the definition of efficacy. Antagonists may possess negative efficacy, Trends Pharmacol Sci, 15, 408, 10.1016/0165-6147(94)90086-8 Kenakin, 1993 Kramer, 1993, In vitro potency, affinity, and agonist efficacy of highly selective delta opioid receptor ligands, J Pharmacol Exp Ther, 266, 577 Leff, 1988, Analysis of agonist action using the operational model, Trends Pharmacol Sci, 9, 395, 10.1016/0165-6147(88)90065-X Leff, 1995, The two-state model of receptor activation, Trends Pharmacol Sci, 16, 89, 10.1016/S0165-6147(00)88989-0 Leff, 1990, Pharmacological estimation of agonist affinity: Detection of errors that may be caused by the operation of receptor isomerisation or ternary complex mechanisms, Br J Pharmacol, 101, 55, 10.1111/j.1476-5381.1990.tb12088.x Leff, 1990, Estimation of agonist affinity and efficacy by direct, operational model-fitting, J Pharmacol Meth, 23, 225, 10.1016/0160-5402(90)90066-T Mackay, 1988, Concentration-response curves and receptor classification: Null method or operational model?, Trends Pharmacol Sci, 9, 202, 10.1016/0165-6147(88)90085-5 Press, 1990 Quastel, 1993, An introduction to the mathematics of drug-receptor interaction and dose-response curves, Current Topics in Mol Pharmacol, 1, 97 Stephenson, 1956, A modification of receptor theory, Br J Pharmacol, 11, 379 Walker, 1995, Buprenorphine antagonism of mu opioids in the rhesus monkey tail-withdrawal procedure, J Pharmacol Exp Ther, 273, 1345 Wolfram, 1991 Young, 1984, Antagonism of the discriminative effects of ethylketazocine, cyclazocine, and nalorphine in macaques, Psychopharmacology, 84, 356, 10.1007/BF00555213 Zernig, 1994, In vivo determination of mu opiod receptor turnover in rhesus monkeys after irreversible blockade with clocinnamox, J Pharmacol Exp Ther, 269, 57 Zernig, 1995, Receptor reserve and affinity of mu opioid agonists in mouse antinociception: Correlation with receptor binding, Life Sci, 57, 2113, 10.1016/0024-3205(95)02204-V Zernig, 1996, Clocinnamox effects on intravenous self-administration of mu opiod agonists and cocaine by rhesus monkeys: Agonist efficacy and affinity estimates, NIDA Res Monogr Zernig, 1995